Article Information
PubMed
Published By
History
- Received October 31, 2017
- Revision received December 14, 2017
- Accepted December 15, 2017
- Published online January 9, 2018.
Copyright & Usage
Copyright © 2018 Hoops et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- 1Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec H4H 1R3, Canada
- 2Integrated Program in Neuroscience, McGill University, Montreal, Quebec H3A 1A1, Canada
- Correspondence should be addressed to Dr. Cecilia Flores, Douglas Mental Health University Institute, Perry Pavilion, Room #2111, 6875 LaSalle Boulevard, Montréal (Verdun), Quebec H4H 1R3, Canada, E-mail: cecilia.flores{at}mcgill.ca.
Author contributions
Author contributions: D.H. and C.F. designed research; D.H., L.M.R., and J.-M.R.-L. performed research; D.H. and C.F. analyzed data; D.H. and C.F. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by National Institute on Drug Abuse Grants R01DA037911 (to C.F.) and F31DA041188 (to L.M.R.), the Natural Science and Engineering Research Council of Canada Grant 2982226 (to C.F.), the Canadian Institutes of Health Research Grant MOP-74709 (to C.F.), and the Quebec Nature and Technology Research Fund Grant 208332 (to D.H.). C.F. is a research scholar of the Fonds de Recherche du Québec-Santé.
Funding
HHS | NIH | National Institute on Drug Abuse (NIDA)
R01DA037911; F31DA041188National Science and Engineering Research Council of Canada (NSERC)
2982226Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)
MOP-74709Quebec Nature and Technology Research Fund (FRQNT)
208332
Other Version
- You are viewing the most recent version of this article.
- previous version (January 09, 2018).
Article usage
In this issue
Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence
